Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to prevent or treat hypokalemia. It is available in various oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Replacement therapy for potassium loss due to diuretics, diarrhea, vomiting, or other causes. ## Adult Dosing * **Oral Prevention of Hypokalemia:** 20 mEq (1.5 g) once daily. * **Oral Treatment of Hypokalemia:** 40-100 mEq (3-7.5 g) per day in divided doses, depending on severity. Maximum daily oral dose is generally 200 mEq (15 g). * **Intravenous Treatment of Hypokalemia:** Dosing is highly individualized based on serum potassium levels, severity of deficit, and clinical status. **Specific IV dosing, infusion rates, and maximum concentrations are dependent on local protocol and patient factors.** Typically, doses range from 10 mEq to 40 mEq per dose. Infusion rates should not exceed 10-20 mEq/hour, and concentrations should generally not exceed 40 mEq/L in peripheral lines, or 80 mEq/L in central lines, to prevent phlebitis and pain. **Rapid infusion of concentrated potassium is dangerous and can be fatal.** ## Pediatric Dosing * **Oral Prevention of Hypokalemia:** Typically 1-2 mEq/kg/day, not to exceed adult doses. * **Oral Treatment of Hypokalemia:** 2-5 mEq/kg/day in divided doses. * **Intravenous Treatment of Hypokalemia:** Similar to adults, dosing is individualized and dependent on serum potassium, severity, and patient status. **Specific IV dosing, infusion rates, and maximum concentrations are dependent on local protocol.** Generally, maintenance requirement is 1-2 mEq/kg/day, not exceeding 100 mEq/day. Repletion doses are higher. **IV potassium administration in pediatrics requires extreme caution and close monitoring.** ## Dose Adjustments * Renal Impairment: Use with extreme caution. Reduced dosage may be necessary. Monitor potassium levels closely. * Adrenal Insufficiency: Higher risk of hyperkalemia. ## Contraindications * Hyperkalemia. * Conditions that may predispose to hyperkalemia (e.g., severe renal impairment, untreated Addison's disease, certain crush injuries, extensive tissue burns). * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Gastrointestinal:** Nausea, vomiting, abdominal pain, diarrhea, flatulence. Esophageal or gastric irritation/perforation (especially with undissolved tablets or capsules). * **Cardiovascular:** Arrhythmias, cardiac arrest (especially with rapid IV infusion or hyperkalemia). * **Other:** Hyperkalemia, particularly in patients with renal impairment or those taking potassium-sparing agents. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors (e.g., lisinopril, enalapril) and Angiotensin II Receptor Blockers (ARBs) (e.g., losartan, valsartan):** Increased risk of hyperkalemia. * **NSAIDs:** May impair renal excretion of potassium, increasing risk of hyperkalemia. * **Heparin:** May impair renal excretion of potassium, increasing risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase the risk of digoxin toxicity. Hypokalemia can decrease digoxin efficacy and increase the risk of arrhythmias. ## Monitoring * Serum potassium levels (frequently, especially with IV administration or dose changes). * Renal function (BUN, creatinine). * ECG changes (especially with IV administration or suspected hyperkalemia). * Signs and symptoms of hypokalemia and hyperkalemia. ## Clinical Pearls * Oral potassium chloride should be taken with food or fluids to minimize gastrointestinal upset. * Effervescent tablets should be dissolved completely in water before administration. * Slow-release formulations may reduce gastrointestinal irritation but can be less predictable for rapid repletion. * Intravenous administration requires careful calculation, slow infusion rates, and continuous cardiac monitoring, especially with higher doses or rapid correction. * Always confirm the concentration and infusion rate with a second licensed professional for IV potassium. *** **Disclaimer:** This information is intended for clinical decision support and does not replace comprehensive drug information resources or professional judgment. Always consult the most current prescribing information and relevant guidelines before making any clinical decisions.